ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
/PRNewswire/ -- ERS Genomics Limited (ERS) is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD (Lepton"). This is a non-exclusive...
Emmanuelle Charpentier Dara Odonnell Daniel Zurr Eric Rhodes Lepton Pharmaceutical Lepton Pharmaceuticals
Source: prnewswire.com